Lonza Buys Roche Site for $1.2 Billion to Bolster Biologics (1)

Lonza Group AG agreed to buy a manufacturing facility in the US from Roche Holding AG for $1.2 billion, adding production capacity in the rapidly growing field of biologic medicines.

The facility in Vacaville, California, is one of the largest biologics manufacturing sites in the world by volume and will complement Lonza’s own site on the East Coast, the company said in a statement on Wednesday. Approximately 750 employees at the facility will be offered employment by Lonza and the products currently produced there by Roche will continue to be supplied by Lonza for a transition period.

Lonza’s biologics division, ...